Don't get me wrong. We must continue to support the goal of conquering cancer. But we must ask the National Cancer Institute to allocate more funding for prevention, and we must research better, more accurate diagnostics.
The FDA and the institutional review boards, rather than being impediments to patients gaining access to potentially life-saving drugs, must become a partner with patients. Regulatory impediments before parents must be eased.
We have become a nation where our leaders can throw billions at places like Goldman Sachs, which does nothing to touch the lives of average Americans, but underfund the war against cancer, which touches almost every family.
Today, with the release of the President's Cancer Panel report, we may see a fundamental shift toward a winning strategy. The Panel levels a hefty critique of failed regulation of environmental contaminants and undue industry influence.